CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(07): E900-E910
DOI: 10.1055/a-1147-8977
Original article

Does a history of head and neck cancer affect outcome of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma?

Renata Nobre Moura
1   Department of Gastroenterology, Cancer Institute, Hospital das Clinicas of University of Sao Paulo, Sao Paulo, Brazil
,
Vitor Nunes Arantes
2   Alfa Institute of Gastroenterology, Hospital de Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil
,
Tarso Magno Leite Ribeiro
2   Alfa Institute of Gastroenterology, Hospital de Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil
,
Roberto Gardone Guimarães
2   Alfa Institute of Gastroenterology, Hospital de Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil
,
Joel Fernandez de Oliveira
1   Department of Gastroenterology, Cancer Institute, Hospital das Clinicas of University of Sao Paulo, Sao Paulo, Brazil
,
Marco Aurélio Vamondes Kulcsar
1   Department of Gastroenterology, Cancer Institute, Hospital das Clinicas of University of Sao Paulo, Sao Paulo, Brazil
,
Rubens Antonio Aissar Sallum
1   Department of Gastroenterology, Cancer Institute, Hospital das Clinicas of University of Sao Paulo, Sao Paulo, Brazil
,
Ulysses Ribeiro-Junior
1   Department of Gastroenterology, Cancer Institute, Hospital das Clinicas of University of Sao Paulo, Sao Paulo, Brazil
,
Fauze Maluf-Filho
1   Department of Gastroenterology, Cancer Institute, Hospital das Clinicas of University of Sao Paulo, Sao Paulo, Brazil
› Author Affiliations

Abstract

Background and study aims Esophageal squamous cell carcinoma (ESCC) is the most common secondary tumor in patients with head and neck squamous cell cancer (HNSCC). Currently, endoscopic submucosal dissection (ESD) is the preferred approach to manage superficial ESCC, however, it remains to be elucidated whether patients with HNSCC and early ESCC managed by ESD have different outcomes.

Patients and methods We retrospectively analyzed esophageal ESD for early ESCC from September 2009 to September 2017 and the following variables: demographics, tumor and specimen size, Paris classification, location, en bloc and R0 resection rates, overall survival (OS) and adverse events (AEs). To reduce selection bias, propensity score matching was applied to compare the results.

Results Eighty-nine ESDs were performed in 81 consecutive patients (47 with HNSCC and 34 without HNSCC). Patients with HNSCC who developed superficial ESCC were found to be younger and to refer a more frequent history of alcohol ingestion and smoking. There was no difference in lesion size, number of lesions, procedure time, en bloc resection rate, R0 resection rate, local recurrence and adverse event rate between the two groups. The histological depth of invasion for patients with HNSCC was significantly shallower before (P = 0.016) and after (P = 0.047) matching. The overall survival rate was similar in both groups.

Conclusions Patients with HNSCC have earlier detection of ESCC, probably due to endoscopic screening. Previous history of chemoradiation and surgery for HNSCC does not affect procedure time, AEs and OS.



Publication History

Received: 03 September 2019

Accepted: 17 February 2020

Article published online:
16 June 2020

© 2020. Owner and Copyright ©

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Lim H, Kim DH, Jung HY. et al. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver 2015; 9: 159-166
  • 2 Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: A meta-analysis. Dig Dis Sci 2014; 59: 1862-1869
  • 3 Fukuhara T, Hiyama T, Tanaka S. et al. Characteristics of Esophageal squamous cell carcinomas and Lugol-voiding lesions in patients with head and neck squamous cell carcinoma. J Clin Gastroenterol 2010; 44: e27-e33
  • 4 Watanabe S, Ogino I, Inayama Y. et al. Impact of the early detection of esophageal neoplasms in hypopharyngeal cancer patients treated with concurrent chemoradiotherapy. Asia Pac J Clin Oncol 2017; 13: e3-e10
  • 5 Kandiah K, Chedgy FJQ, Subramaniam S. et al. Early squamous neoplasia of the esophagus: The endoscopic approach to diagnosis and management. Saudi J Gastroenterol 2017; 23: 75-81
  • 6 Arantes V, Albuquerque W, Salles JMP. et al. Effectiveness of unsedated transnasal endoscopy with white-light, flexible spectral imaging color enhancement, and lugol staining for esophageal cancer screening in high-risk patients. J Clin Gastroenterol 2013; 47: 314-321
  • 7 Ide E, Maluf-Filho F, Chaves DM. et al. Narrow-band imaging without magnifcation for detecting early esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17: 4408-4413
  • 8 Pimentel-Nunes P, Ponchon T, Repici A. et al. Endoscopic submucosal dissection : European Society of Gastrointestinal Endoscopy ( ESGE ) Guideline. Endoscopy 2015; 47: 829-854
  • 9 Ono S, Fujishiro M, Niimi K. et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 2009; 70: 860-866
  • 10 Rizvi Q ul ain, Balachandran A, Koay D. et al. Endoscopic management of early esophagogastric cancer. Surg Oncol Clin N Am 2017; 26: 179-191
  • 11 Yamamoto H, Oyama T, Gotoda T. Endoscopic submucosal dissection. esophageal cancer and Barrett’s esophagus 2015; 177-188
  • 12 Arantes V, Albuquerque W, Freitas Dias CA. et al. Standardized endoscopic submucosal tunnel dissection for management of early esophageal tumors (with video). Gastrointest Endosc 2013; 78: 946-952
  • 13 Chow TL, Lee DTY, Choi CY. et al. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: A multivariate analysis. Arch Otolaryngol – Head Neck Surg 2009; 135: 882-885
  • 14 Rice TW, Blackstone EH, Rusch VW. Editorial: 7th edition of the AJCC cancer staging manual: Esophagus and esophagogastric junction. Ann Surg Oncol 2010; 17: 1721-1724
  • 15 Schlemper RJ, Riddell RH, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
  • 16 Kuwano H, Nishimura Y, Oyama T. et al. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus 2015; 12: 1-30
  • 17 Chen Y, Zhao Y, Zhao X. et al. Clinical outcomes of endoscopic submucosal dissection for early esophageal squamous cell neoplasms: a retrospective single-center study in China. Gastroenterol Res Pract 2016; 2016
  • 18 Toyonaga T, Man-I M, East JE. et al. 1,635 endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: Complication rates and long-term outcomes. Surg Endosc 2013; 27: 1000-1008
  • 19 Fujinami H, Hosokawa A, Ogawa K. et al. Endoscopic submucosal dissection for superficial esophageal neoplasms using the stag beetle knife. Dis Esophagus 2014; 27: 50-54
  • 20 Mochizuki Y, Saito Y, Tsujikawa T. et al. Combination of endoscopic submucosal dissection and chemoradiation therapy for superficial esophageal squamous cell carcinoma with submucosal invasion. Exp Ther Med 2011; 2: 1065-1068
  • 21 Repici A, Hassan C, Carlino A. et al. Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 2010; 71: 715-721
  • 22 Teoh A, Chiu P, Ngo D. et al. Outcomes of endoscopic submucosal dissection versus endoscopic mucosal resection in management of superficial squamous esophageal neoplasms outside Japan. J Clin Gastroenterol 2010; 44: e190-e194
  • 23 Yamashina T, Ishihara R, Uedo N. et al. Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50 mm in diameter. Gastroenterol Endosc 2014; 56: 515-521
  • 24 Takahashi H, Arimura Y, Masao H. et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010; 72: 255-264
  • 25 Choi JY, Park YS, Jung HY. et al. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc 2011; 73: 881-889
  • 26 Joo DC, Kim GH, Park DY. et al. Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: A single-center study. Gut Liver 2014; 8: 612-618
  • 27 Park HC, Kim DH, Gong EJ. et al. Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center. Korean J Intern Med 2016; 31: 1064-1072
  • 28 Youn YH, Park J, Park JJ. et al. Tu1580 clinical outcomes of endoscopic submucosal dissection for superficial esophageal squamous neoplasms. Gastrointest Endosc 2015; 81: AB517
  • 29 Probst A, Aust D, Markl B. et al. Early esophageal cancer in Europe: Endoscopic treatment by endoscopic submucosal dissection. Endoscopy 2015; 47: 113-121
  • 30 Tsujii Y, Nishida T, Nishiyama O. et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy 2015; 47: 775-783
  • 31 Lee CT, Chang CY, Tai CM. et al. Endoscopic submucosal dissection for early esophageal neoplasia: A single center experience in South Taiwan. J Formos Med Assoc 2012; 111: 132-139
  • 32 Nakahara T, Kushima R, Fujiyama Y. et al. Chemoradiation therapy followed by endoscopic submucosal dissection for esophageal cancer. Dig Dis Sci 2008; 53: 3242-3245
  • 33 Nakajo K, Yoda Y, Hori K. et al. Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc 2018; 88: 637-646
  • 34 Watanabe N, Jin M, Kimura Y. et al. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy. Gastrointest Endosc 2013; 79: 348-353
  • 35 Victor CR, Fujiki FK, Takeda FR. et al. Safety and effectiveness of chemotherapy for metastatic esophageal cancer in a community hospital in Brazil. J Glob Oncol 2019; 1-10